GA-based CDMO picked up by private equity
The middle-market private equity firm Nautic Partners has acquired Mikart, an Atlanta, GA-headquartered contract development and manufacturing organization (CDMO).
Archives for October 1, 2018
Exostar acquires Pirean to simplify data, clinical application access
The identity and access management firm Exostar has acquired UK-headquartered Pirean Limited to provide the pharma industry with simplicity, speed, and security, says VP.
NLP engine aims to improve patient outcomes through efficient data review
LabKey and Linguamatics have designed an integrated NLP data management solution to help accelerate clinical data abstraction and curation of unstructured notes and reports for clinical research.
US DEA action gives GW Pharma’s CBD drug the go-ahead
The DEA has placed GW Pharma’s cannabinoid treatment, Epidiolex, in the least restrictive scheduling of controlled substances.
Cambrex cements North Carolina presence with buildings purchase
Cambrex, a small molecule and API manufacturer, announced it will expand to establish a ‘center of excellence’ for process and development of its API clinical supply.
Delays at MSD’s CMO prompt Sinemet shortage
MSD has warned regulators to expect a shortage of its Parkinson’s medicine, Sinemet, due to production constraints at a contract manufacturer’s facility.
The global future of medicine: Higher volume at a lower price?
The issue of pricing is a familiar discussion for the pharma industry and Ruchin Kansal, of Virtusa, believes that there is the potential for a win-win situation.